ARCHIVES

In Brief: Sartorelli Replaces Cole As Director Of Yale Comprehensive Center; NSABP Ends Segmental Trials

This article is from The Cancer Letter archive.

Vol. 10 No. 09 | March 2, 1984

Download PDF Visit The Full Archive

Related Articles

Clinton Proposes Increase For Science And Technology.

February 4, 2000

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

July 25, 2014

NCI Gets Withheld Funds; Hazleton Tops List In Stepped-Up Award Flow

April 4, 1975

Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds

October 31, 2003

NCI Approved CTEP Trials For the Month of August

August 31, 2012

Cancer Meetings Listed

March 26, 1993